during continued treatment with bezafibrate the investigated parameters remained at their achieved levels , whereas with both epl and placebo there was a renewed increase of cholesterol , triglycerides , fasting blood sugar and hba1 and a decrease of hdl-cholesterol to values before bezafibrate treatment .
C0008377
cholesterol
C0023822
hdl-cholesterol